Skip to product information
$440.00
Description
Retatrutide is a highly promising investigational peptide, primarily for the treatment of obesity and Type 2 diabetes mellitus.
It represents a breakthrough as a triple hormone receptor agonist (nicknamed the "Triple G") because it is the first peptide in development to simultaneously target three key metabolic pathways:
- GLP-1 (Glucagon-like peptide-1) Receptor: Suppresses appetite, slows digestion, and enhances insulin release.
- GIP (Glucose-dependent insulinotropic polypeptide) Receptor: Improves insulin sensitivity and aids in fat metabolism and blood sugar reduction.
- Glucagon Receptor (GCGR): This unique third component promotes the breakdown of stored fat for energy (lipolysis) and increases energy expenditure.
Shipping
We use Australia Post Express Shipping for all deliveries within Australia.
Estimated delivery time is 2–4 business days after dispatch, depending on your location.
Please note: We guarantee dispatch, not delivery. Once your parcel is handed to the courier, we are not liable for any delays, damages, or losses beyond our control.